Xuesong Wu
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
NF-κB/Lipocalin 2 Signaling Pathway Mitigates the Chemoresistance of BRAFV600E-Mutant Colorectal Cancer to Cisplatin by Promoting Ferroptosis.
Journal: Cancers
Published: July 02, 2026
Loss of Lipocalin2 confers cisplatin vulnerability through modulating NF-ĸB mediated ferroptosis via ferroportin.
Journal: American journal of cancer research
Published: January 04, 2024
The expression of SP263 in muscle invasive bladder carcinoma and its relationship with clinicopathological features.
Journal: Indian journal of pathology & microbiology
Published: December 12, 2023
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 14, 2023
Study on Molecular Information Intelligent Diagnosis and Treatment of Bladder Cancer on Pathological Tissue Image.
Journal: Frontiers in medicine
Published: December 17, 2021
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer.
Journal: Cancer & metabolism
Published: February 19, 2021
S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-β/USF2 axis in colorectal cancer.
Journal: Cancer communications (London, England)
Published: July 30, 2020
Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
Journal: Clinical colorectal cancer
Published: April 24, 2018
Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.
Journal: Oncoimmunology
Published: July 25, 2017
Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Journal: Molecular cancer
Published: July 20, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026